Literature DB >> 7417055

Proximal muscle weakness in uremia. Case reports and review of the literature.

R P Lazaro, H S Kirshner.   

Abstract

Weakness of the proximal muscle groups developed in six uremic patients, five men and one woman, while receiving hemodialysis. All showed roentgenographic evidence of renal osteodystrophy. Partial to complete recovery of strength followed subtotal parathyroidectomy in four patients. All patients had normal levels of creatine phosphokinase. Electrodiagnostic testing showed features of both "myopathic" and denervating processes on coaxial needle exploration and normal to slowed nerve conduction. Muscle biopsy specimens in four patients showed type 2 fiber atrophy with no evidence of necrosis, phagocytosis, regeneration, or vasculitis. The pathogenesis of proximal muscle weakness in uremia is uncertain but may be related to secondary hyperparathyroidism or osteodystrophy.

Entities:  

Mesh:

Year:  1980        PMID: 7417055     DOI: 10.1001/archneur.1980.00500580051007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

1.  Acute neuromyopathy after colchicine treatment.

Authors:  J van der Naalt; H Haaxma-Reiche; A P van den Berg; B P Hazenberg; W M Molenaar
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 2.  Effect of uremia and its treatment on pulmonary function.

Authors:  D J Prezant
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients.

Authors:  G E Moore; L A Bertocci; P L Painter
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 4.  Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

Authors:  Bruno-Pierre Dubé; Pierantonio Laveneziana
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 5.  Morphological, electrophysiological, and metabolic characteristics of skeletal muscle in people with end-stage renal disease: a critical review.

Authors:  Anuradha Sawant; S Jayne Garland; Andrew A House; Tom J Overend
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

6.  The case for routine parathyroid hormone monitoring.

Authors:  Stuart M Sprague; Sharon M Moe
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

7.  Dialysis myopathy. Report of 13 cases.

Authors:  J Bautista; E Gil-Necija; J Castilla; I Chinchon; E Rafel
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  EMG changes in chronically dialyzed uraemic subjects undergoing d, 1-Carnitine treatment.

Authors:  P M Rossini; L Marchionno; D Gambi; M Pirchio; G Del Rosso; A Albertazzi
Journal:  Ital J Neurol Sci       Date:  1981-08

9.  Role of vitamin D3 in treatment of lumbar disc herniation--pain and sensory aspects: study protocol for a randomized controlled trial.

Authors:  Mahsa Sedighi; Ali Haghnegahdar
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

10.  CKD autophagy activation and skeletal muscle atrophy-a preliminary study of mitophagy and inflammation.

Authors:  Yue Yue Zhang; Li Jie Gu; Jin Fang Bao; Wei Jie Yuan; Juan Huang; Min Chao Cai; Hong Lei Yu; Wei Zhang
Journal:  Eur J Clin Nutr       Date:  2019-01-03       Impact factor: 4.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.